Insider · CIK 0001368924

Freddo James L

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001368924

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-02-08	Ignyta, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	$27.00	−$81K	0
2018-02-08	Ignyta, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,666 sh	—	—	0
2018-02-08	Ignyta, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24K sh	—	—	0
2018-02-08	Ignyta, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2018-02-08	Ignyta, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2018-02-08	Ignyta, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2017-06-13	Ignyta, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-06-13	Ignyta, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-03-17	Ignyta, Inc.P Purchase	Director	PPurchase	+3,000 sh	$5.39	+$16.2K	3,000
2014-08-11	Ignyta, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2011-01-20	ANADYS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, SVP, Drug Development and CMO	AAward	+50K sh	—	—	50,000
2010-12-13	ANADYS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, SVP, Drug Development and CMO	AAward	+71.4K sh	—	—	71,438
2010-12-03	INFUInfuSystem Holdings, Inc · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	—	—	0
2010-12-03	INFUInfuSystem Holdings, IncA Award	Director	AAward	+75K sh	—	—	115,000
2010-04-08	INFUInfuSystem Holdings, Inc · Restricted Stock AwardA Award	Director	AAward	+75K sh	—	—	75,000
2009-12-03	ANADYS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, SVP, Drug Development and CMO	AAward	+73.5K sh	—	—	73,500
2009-08-18	ANADYS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, SVP, Drug Development and CMO	AAward	+35K sh	—	—	35,000
2008-08-05	ANADYS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, SVP, Drug Development and CMO	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Feb 124
Freddo James L0001209191-18-009143
SEC(opens sec.gov)
Jun 194
Ignyta, Inc.0001209191-17-040966
SEC(opens sec.gov)
Jun 154
Ignyta, Inc.0001209191-16-127920
SEC(opens sec.gov)
Mar 214
Ignyta, Inc.0001209191-16-109690
SEC(opens sec.gov)
Aug 114
Ignyta, Inc.0001209191-14-051722
SEC(opens sec.gov)
Jan 244
Freddo James L0001209191-11-004658
SEC(opens sec.gov)
Dec 154
Freddo James L0001209191-10-060792
SEC(opens sec.gov)
Dec 74
Freddo James L0001181431-10-059825
SEC(opens sec.gov)
Apr 124
InfuSystem Holdings, Inc0001181431-10-021202
SEC(opens sec.gov)
Dec 74
Freddo James L0001209191-09-055741
SEC(opens sec.gov)
Aug 204
Freddo James L0001209191-09-041455
SEC(opens sec.gov)
Aug 64
ANADYS PHARMACEUTICALS INC0001209191-08-045743
SEC(opens sec.gov)

Companies

Address

C/O ANADYS PHARMACEUTICALS, INC. 5871 OBERLIN DRIVE, SUITE 200

SAN DIEGO, CA, 92121